XML 47 R18.htm IDEA: XBRL DOCUMENT v3.19.3
DERIVATIVE FINANCIAL INSTRUMENTS
3 Months Ended
Sep. 28, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS
Derivative Financial Instruments
As of September 28, 2019, the Company had outstanding foreign currency forward contracts with a total notional amount of $33.0 million. The maturity dates for these contracts extend through December 2020. For the three months ended September 28, 2019, the Company did not enter into any foreign currency forward contracts and settled $6.7 million of such contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $5.3 million of such contracts.
As of September 28, 2019, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains are expected to mature as summarized below (in thousands):
Quarter Ending
 
Notional Contracts in MXN
 
Notional Contracts in USD
 
Estimated Fair Value
December 28, 2019
 
$
152,613

 
$
7,187

 
$
508

March 28, 2020
 
$
146,613

 
$
6,553

 
$
736

June 27, 2020
 
$
138,213

 
$
6,257

 
$
525

September 26, 2020
 
$
141,173

 
$
6,729

 
$
117

December 26, 2020
 
$
132,773

 
$
6,241

 
$
125


On October 1, 2014, the Company entered into an interest rate swap contract with an effective date of September 1, 2015 and a termination date of September 3, 2019, related to the borrowings outstanding under the term loan. This interest rate swap paid the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract was 1.97% that replaced the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge.
The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of September 28, 2019 and June 29, 2019 (in thousands):
 
 
 
September 28, 2019
 
June 29, 2019
Derivatives Designated as Hedging Instruments
Balance Sheet Location
 
Fair Value
 
Fair Value
Foreign currency forward contracts & swaps
Other current assets
 
$
1,886

 
$
2,912

Foreign currency forward contracts & swaps
Other long-term assets
 
$
125

 
$
320

Interest rate swap
Other current assets
 
$

 
$
2



The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended September 28, 2019 and September 29, 2018, respectively (in thousands):
Derivatives Designated as Hedging Instruments
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
 
AOCI Balance
as of
June 29, 2019
 
Effective
Portion
Recorded In
AOCI
 
Effective Portion
Reclassified From
AOCI Into
Income
 
AOCI Balance
as of
September 28, 2019
Forward contracts & swaps
Cost of sales
 
$
2,424

 
$
(41
)
 
$
(904
)
 
$
1,479

Interest rate swap
Interest expense
 
2

 

 
(2
)
 

Total
 
 
$
2,426

 
$
(41
)
 
$
(906
)
 
$
1,479

 
 
 
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
 
AOCI Balance
as of
June 30, 2018
 
Effective
Portion
Recorded In
AOCI (1)
 
Effective Portion
Reclassified From
AOCI Into
Income
 
AOCI Balance
as of
September 29, 2018
Forward contracts & swaps
Cost of sales
 
$
(988
)
 
$
2,515

 
$
534

 
$
2,061

Interest rate swap
Interest expense
 
19

 
2

 
(2
)
 
19

Total
 
 
$
(969
)
 
$
2,517

 
$
532

 
$
2,080

As of September 28, 2019, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately $1.5 million. As of September 28, 2019, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.